Clinical trials
2 active studies led by Zenflow, Inc., of 7 in all
Source: ClinicalTrials.gov, Studies with Zenflow, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 2Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Zenflow, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Zenflow, Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
US device clearances
2 510(k) clearances and PMA approvals since 2015
- Zenflow Spring® Implant And Delivery System Stent, Urethral, Prostatic, Permane… P250007 · 11 Dec 2025
- Zenflow Spring Scope K251140 · 23 Sep 2025
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Trials over time
Studies Zenflow, Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Zenflow, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Zenflow, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Zenflow, Inc. is in.
From our blog
Stories on the topics Zenflow, Inc. works in.
Men's Health Supplements: Beyond the Marketing
Only about a quarter of testosterone booster products had study data showing they raise testosterone. Sexual…
Read
Fertility Services: Rising Demand and Access Gaps
About 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income.
Read
Hair Loss Treatments: What Works
In 2022 the FDA approved the first pill for severe alopecia areata, which affects more than 300,000 people in…
Read